Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesna for Homocysteine Removal in ESRD
NCT00524199Phase 2Completed
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in hyperhomocysteinemia comparing Mesna with Placebo (2 arms). Primary endpoint: Difference in plasma total homocysteine between placebo and mesna treatments at 4 weeks. Started Mar 2007; status: completed.
02
Drugs
mesna
03
Conditions
hyperhomocysteinemia
Beyond the preview
Go deeper on NCT00524199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524199.